Last reviewed · How we verify

NCT05716867

Salivary Cystatin S Levels in a Group of Egyptian Children

Active, enrolled Last updated 17 February 2025
What this trial tests

trial testing Measurement of salivary cystatin S protein levels in saliva in Early Childhood Caries in 30 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 December 2023
Primary endpoint
15 December 2024
10 May 2025

Quick facts

Lead sponsorCairo University
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment30
Start date1 December 2023
Primary completion15 December 2024
Estimated completion10 May 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 36 Months to 71 Months, any sex, with Early Childhood Caries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim of the study 1. Measuring the levels of salivary cystatin S protein and salivary buffering capacity to determine their relation to early childhood caries. 2. Predection of early childhood caries by using salivary cystatin S levels with demographic, clinical and nutrition habits characteristics of the participants.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Early Childhood Caries

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05716867.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing